JPH0411194B2 - - Google Patents
Info
- Publication number
- JPH0411194B2 JPH0411194B2 JP10838187A JP10838187A JPH0411194B2 JP H0411194 B2 JPH0411194 B2 JP H0411194B2 JP 10838187 A JP10838187 A JP 10838187A JP 10838187 A JP10838187 A JP 10838187A JP H0411194 B2 JPH0411194 B2 JP H0411194B2
- Authority
- JP
- Japan
- Prior art keywords
- methoxyphenyl
- aminopropane
- bacterial cells
- propanone
- ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000001580 bacterial effect Effects 0.000 claims description 22
- WFWKNGZODAOLEO-UHFFFAOYSA-N 1-(4-Methoxyphenyl)-2-propanone Chemical compound COC1=CC=C(CC(C)=O)C=C1 WFWKNGZODAOLEO-UHFFFAOYSA-N 0.000 claims description 17
- 244000005700 microbiome Species 0.000 claims description 13
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 claims description 13
- 241000186146 Brevibacterium Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 235000012539 Bacterium linens Nutrition 0.000 description 3
- 241000186310 Brevibacterium linens Species 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- NEGYEDYHPHMHGK-QMMMGPOBSA-N (2s)-1-(4-methoxyphenyl)propan-2-amine Chemical compound COC1=CC=C(C[C@H](C)N)C=C1 NEGYEDYHPHMHGK-QMMMGPOBSA-N 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical group NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
- 235000019289 ammonium phosphates Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NEGYEDYHPHMHGK-MRVPVSSYSA-N (2r)-1-(4-methoxyphenyl)propan-2-amine Chemical compound COC1=CC=C(C[C@@H](C)N)C=C1 NEGYEDYHPHMHGK-MRVPVSSYSA-N 0.000 description 1
- ORLFVWPPBMVPNZ-UHFFFAOYSA-N 1-(6-methylheptyl)-4-[4-(6-methylheptyl)phenoxy]benzene Chemical compound C1=CC(CCCCCC(C)C)=CC=C1OC1=CC=C(CCCCCC(C)C)C=C1 ORLFVWPPBMVPNZ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000001729 Ammonium fumarate Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241001524175 Glutamicibacter protophormiae Species 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 235000019297 ammonium fumarate Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- CKKXWJDFFQPBQL-SEPHDYHBSA-N azane;(e)-but-2-enedioic acid Chemical compound N.N.OC(=O)\C=C\C(O)=O CKKXWJDFFQPBQL-SEPHDYHBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000003163 cell fusion method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- ISYORFGKSZLPNW-UHFFFAOYSA-N propan-2-ylazanium;chloride Chemical compound [Cl-].CC(C)[NH3+] ISYORFGKSZLPNW-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
(技術分野)
本発明は酵素法による1−(4−メトキシフエ
ニル)−2−アミノプロパンの製法に関する。DETAILED DESCRIPTION OF THE INVENTION (Technical Field) The present invention relates to a method for producing 1-(4-methoxyphenyl)-2-aminopropane by an enzymatic method.
(従来技術)
酵素法により1−(4−メトキシフエニル)−2
−プロパノンから1−(4−メトキシフエニル)−
2−アミノプロパンを得る方法は、従来全く知ら
れていない。(Prior art) 1-(4-methoxyphenyl)-2 by enzymatic method
-Propanone to 1-(4-methoxyphenyl)-
A method for obtaining 2-aminopropane has been completely unknown so far.
(発明の構成及び効果)
本発明の目的化合物である1−(4−メトキシ
フエニル)−2−アミノプロパンは、気管支拡張
作用を有する優れた医薬化合物であるカルボスチ
リル誘導体(特開昭60−208965号)の原料として
重要な物質である。本発明者らはこの1−(4−
メトキシフエニル)−2−アミノプロパンの製造
方法について研究を重ねた結果、ブレビバクテリ
ウム属などの微生物に1−(4−メトキシフエニ
ル)−2−プロパノンを1−(4−メトキシフエニ
ル)−2−アミノプロパンに特異的に転換せしめ
る能力があることを見出し、本発明を完成した。(Structure and Effects of the Invention) 1-(4-methoxyphenyl)-2-aminopropane, which is the target compound of the present invention, is a carbostyril derivative (Japanese Patent Application Laid-Open No. 1989-1979-1), which is an excellent pharmaceutical compound having bronchodilatory action. No. 208965) is an important material as a raw material. The present inventors obtained this 1-(4-
As a result of repeated research on the production method of 1-(4-methoxyphenyl)-2-aminopropane, it was found that 1-(4-methoxyphenyl)-2-propanone was converted into 1-(4-methoxyphenyl)-2-propanone using microorganisms such as Brevibacterium. The present invention was completed based on the discovery that the present invention has the ability to specifically convert -2-aminopropane.
即ち、本発明は、1−(4−メトキシフエニル)
−2−プロパノンから1−(4−メトキシフエニ
ル)−2−アミノプロパンを生成させる能力を有
するブレビバクテリウム属微生物の培養液、該培
養液から採取した菌体、または菌体の処理物を1
−(4−メトキシフエニル)−2−プロパノンに作
用させ、生成した1−(4−メトキシフエニル)−
2−アミノプロパンを採取することを特徴とする
1−(4−メトキシフエニル)−2−アミノプロパ
ンの製法である。 That is, the present invention provides 1-(4-methoxyphenyl)
- A culture solution of a Brevibacterium microorganism capable of producing 1-(4-methoxyphenyl)-2-aminopropane from 2-propanone, bacterial cells collected from the culture solution, or a processed product of the bacterial cells. 1
1-(4-methoxyphenyl)- produced by reacting with -(4-methoxyphenyl)-2-propanone
This is a method for producing 1-(4-methoxyphenyl)-2-aminopropane, which is characterized by collecting 2-aminopropane.
本発明に使用されるブレビバクテリウム属微生
物としては、1−(4−メトキシフエニル)−2−
プロパノンから1−(4−メトキシフエニル)−2
−アミノプロパンを生成させる能力を有するブレ
ビバクテリウム属微生物であればよく、具体的に
はブレビバクテリウム・リネンス
(Brevibacterium linens)IFO12141、ブレビバ
クテリウム・プロトフオルミエ
(Brevibacterium protophormiae)IFO12128等
があげられる。これらの微生物は、野性株、変異
株、または細胞融合法もしくは遺伝子操作法など
の遺伝的手法により誘導される組み換え株等、い
ずれの株でも好適に用いることができる。 The Brevibacterium genus microorganism used in the present invention includes 1-(4-methoxyphenyl)-2-
1-(4-methoxyphenyl)-2 from propanone
- Any microorganism of the genus Brevibacterium that has the ability to produce aminopropane may be used, and specific examples include Brevibacterium linens IFO12141, Brevibacterium protophormiae IFO12128, and the like. Any strain of these microorganisms can be suitably used, such as a wild strain, a mutant strain, or a recombinant strain induced by a genetic method such as a cell fusion method or a genetic manipulation method.
上記微生物を培養する培地は特に限定されず、
微生物の培養に用い得るものであればよい。例え
ば、炭素源としては、上記微生物の利用可能なも
のであればいずれも使用でき、具体的には、グル
コース、フルクトース、シユクロース、デキスト
リン等の糖類、グリセロール、ソルビトール等の
糖アルコール、フマル酸、クエン酸等の有機酸を
使用することができる。これら炭素源の培地への
添加量は通常0.1〜10%程度とするのが好ましい。
窒素源としては、例えば塩化アンモニウム、硫酸
アンモニウム、リン酸アンモニウム等の無機酸の
アンモニウム塩、フマル酸アンモニウム、クエン
酸アンモニウム等の有機酸のアンモニウム塩、肉
エキス、酵母エキス、コーンステイープリカー、
カゼイン加水分解物等の天然有機窒素源等を使用
することができ、このうち有機窒素源は多くの場
合、炭素源として兼用することができる。窒素源
の添加量は通常0.1〜10%の範囲が適当である。
また無機塩類としては例えばリン酸カリウム、リ
ン酸ナトリウム等のリン酸アルカリ金属、塩化カ
リウム、塩化ナトリウム等の塩化アルカリ金属、
硫酸マグネシウム、硫酸第一鉄等の硫酸金属塩等
を好適に使用することができ、その使用量は通常
0.001〜1%の範囲が適当である。 The medium for culturing the above microorganisms is not particularly limited,
Any material that can be used for culturing microorganisms may be used. For example, as a carbon source, any carbon source that can be used by the microorganisms mentioned above can be used. Specifically, sugars such as glucose, fructose, sucrose, and dextrin, sugar alcohols such as glycerol and sorbitol, fumaric acid, and citric acid can be used as carbon sources. Organic acids such as acids can be used. The amount of these carbon sources added to the medium is preferably about 0.1 to 10%.
Examples of nitrogen sources include ammonium salts of inorganic acids such as ammonium chloride, ammonium sulfate, and ammonium phosphate; ammonium salts of organic acids such as ammonium fumarate and ammonium citrate; meat extracts; yeast extracts; cornstarch liquor;
Natural organic nitrogen sources such as casein hydrolyzate can be used, and in many cases, the organic nitrogen source can also be used as a carbon source. The amount of the nitrogen source added is usually in the range of 0.1 to 10%.
Examples of inorganic salts include alkali metal phosphates such as potassium phosphate and sodium phosphate; alkali metal chlorides such as potassium chloride and sodium chloride;
Sulfate metal salts such as magnesium sulfate and ferrous sulfate can be suitably used, and the amount used is usually
A range of 0.001 to 1% is appropriate.
微生物の培養は20〜40℃とりわけ30〜37℃、PH
約5〜8とりわけPH約6〜7で好気的条件下に実
施するのが好ましい。 Cultivation of microorganisms at 20-40℃, especially 30-37℃, PH
Preferably it is carried out under aerobic conditions at a pH of about 5-8, especially about 6-7.
尚、培地中に1−(4−メトキシフエニル)−2
−アミノプロパンを少量添加しておくと、本発明
の目的化合物の生成能力を高めることができる。
添加する1−(4−メトキシフエニル)−2−アミ
ノプロパンの割合は、使用する微生物により多少
の相違はあるが、通常0.001%以上、とりわけ0.1
〜1%が好ましい。この添加する1−(4−メト
キシフエニル)−2−アミノプロパンは、上記微
生物の培養における窒素源とすることができる。 In addition, 1-(4-methoxyphenyl)-2 was added to the medium.
- Adding a small amount of aminopropane can increase the ability to produce the target compound of the present invention.
The proportion of 1-(4-methoxyphenyl)-2-aminopropane to be added varies slightly depending on the microorganism used, but it is usually 0.001% or more, especially 0.1%.
~1% is preferred. The added 1-(4-methoxyphenyl)-2-aminopropane can be used as a nitrogen source in culturing the above-mentioned microorganism.
かくして得られる培養液、該培養液から採取し
た微生物菌体は、酵素源として好適に使用しう
る。更に、菌体処理物(例えば凍結乾燥菌体、ア
セトン乾燥菌体、洗浄菌体、菌体磨砕物、菌体の
自己消化物、菌体の超音波処理物、菌体抽出物な
ど)を酵素源として用いることもできる。又、菌
体あるいは菌体処理物を、例えばポリアクリルア
ミドゲル法、含硫多糖ゲル法(カラギーナンゲル
法等)、アルギン酸ゲル法、寒天ゲル法等の公知
方法によりで固定化して使用することもできる。
更に、菌体抽出物から公知の方法を組み合わせて
精製取得した酵素も使用することができる。 The culture solution thus obtained and the microbial cells collected from the culture solution can be suitably used as an enzyme source. Furthermore, the bacterial cell-treated product (for example, freeze-dried bacterial cells, acetone-dried bacterial cells, washed bacterial cells, ground bacterial cells, autolysed bacterial cells, ultrasonicated bacterial cells, bacterial cell extracts, etc.) is treated with an enzyme. It can also be used as a source. In addition, the bacterial cells or treated bacterial cells can be immobilized and used by known methods such as polyacrylamide gel method, sulfur-containing polysaccharide gel method (carrageenan gel method, etc.), alginate gel method, agar gel method, etc. .
Furthermore, enzymes purified from bacterial cell extracts using a combination of known methods can also be used.
反応は、培養液、菌体又は菌体処理物と基質で
ある1−(4−メトキシフエニル)−2−プロパノ
ンを混合することによつて行われる。培養後の菌
体を含む培養液に基質を加えて実施しても良く、
又該培養液より得た菌体又は該菌体処理物を基質
の水溶液に加えて反応させても良い。基質の濃度
は概ね0.05〜5%、とりわけ0.1〜1%が好まし
い。反応液のPHは、5〜10、とりわけ6〜9が好
ましい。反応温度は概ね10〜50℃、とりわけ25〜
40℃が好ましい。 The reaction is carried out by mixing the culture solution, bacterial cells, or treated bacterial cells with 1-(4-methoxyphenyl)-2-propanone, which is a substrate. It may be carried out by adding a substrate to the culture solution containing the bacterial cells after culturing,
Alternatively, the bacterial cells obtained from the culture solution or the treated bacterial cells may be added to an aqueous solution of the substrate and reacted. The concentration of the substrate is preferably approximately 0.05 to 5%, particularly 0.1 to 1%. The pH of the reaction solution is preferably 5-10, particularly 6-9. The reaction temperature is generally 10~50℃, especially 25~
40°C is preferred.
また、アミノ基供与体、界面活性剤、補酵素等
の存在下に本反応を実施すれば、反応時間の短
縮、或いは1−(4−メトキシフエニル)−2−ア
ミノプロパンの蓄積量の増加をはかることができ
好ましい。この目的に用いられるアミノ基供与体
の例としては、塩化アンモニウム、硫酸アンモニ
ウム、硝酸アンモニウム、リン酸アンモニウム、
酢酸アンモニウム、ギ酸アンモニウム等のアンモ
ニウム塩、及びL−グルタミン酸、L−アスパラ
ギン酸等のL−アミノ酸が挙げられ、基質に対し
て等モル以上使用するのが好ましい。また界面活
性剤の例としては、臭化セチルピリミジウム、臭
化セチルトリメチルアンモニウム、ポリエチレン
グリコール、p−イソオクチルフエニルエーテル
(米国、ロームアンドハース社製、商品名:トリ
トンX−100)等が挙げられ、反応液に対し、
0.0001〜0.1%程度使用するのが好ましい。更に、
補酵素の例としては、ニコチンアミドアデニンジ
ヌクレオチド(還元型)を挙げることができ、概
ね基質と等モル量用いるのが好ましい。 Furthermore, if this reaction is carried out in the presence of an amino group donor, a surfactant, a coenzyme, etc., the reaction time can be shortened or the amount of 1-(4-methoxyphenyl)-2-aminopropane accumulated can be increased. It is preferable to be able to measure Examples of amino group donors used for this purpose include ammonium chloride, ammonium sulfate, ammonium nitrate, ammonium phosphate,
Examples include ammonium salts such as ammonium acetate and ammonium formate, and L-amino acids such as L-glutamic acid and L-aspartic acid, and it is preferable to use them in equal molar or more to the substrate. Examples of surfactants include cetylpyrimidium bromide, cetyltrimethylammonium bromide, polyethylene glycol, p-isooctylphenyl ether (manufactured by Rohm and Haas, USA, trade name: Triton X-100), etc. For the reaction solution,
It is preferable to use about 0.0001 to 0.1%. Furthermore,
An example of the coenzyme is nicotinamide adenine dinucleotide (reduced type), which is preferably used in an amount approximately equimolar to the substrate.
このようにして反応液中に蓄積した1−(4−
メトキシフエニル)−2−アミノプロパンは酢酸
エチル等の有機溶媒で抽出後、減圧濃縮し、塩酸
酸性にすることで容易に塩酸塩結晶として採取す
ることができる。 1-(4-
Methoxyphenyl)-2-aminopropane can be easily collected as hydrochloride crystals by extracting with an organic solvent such as ethyl acetate, concentrating under reduced pressure, and acidifying with hydrochloric acid.
以上の通り、本願発明方法は工業的安価な1−
(4−メトキシフエニル)−2−プロパノンから酵
素法によつてはじめて医薬化合物の原料として重
要な1−(4−メトキシフエニル)−2−アミノプ
ロパンを製することに成功したものであり、微生
物など酵素反応条件を適宜選択すれば、光学純度
100%の生成物を得ることができるという点を併
せ有する優れた方法である。 As mentioned above, the method of the present invention is an industrially inexpensive 1-
This is the first successful production of 1-(4-methoxyphenyl)-2-aminopropane, which is important as a raw material for pharmaceutical compounds, from (4-methoxyphenyl)-2-propanone by an enzymatic method. Optical purity can be achieved by selecting appropriate enzyme reaction conditions such as microorganisms.
This is an excellent method that can yield 100% product.
以下、本発明を実施例により詳細に説明する。
なお、本明細書中「%」はいずれも「重量/容量
(g/dl)」を意味するものとする。 Hereinafter, the present invention will be explained in detail with reference to Examples.
In addition, in this specification, all "%" shall mean "weight/capacity (g/dl)."
実施例 1
グルコース0.5%、ペプトン1%、肉エキス1
%、酵素エキス1.25%、塩化ナトリウム0.5%か
らなる培地100ml(PH7.0)を500ml容振とうフラ
スコに入れ、120℃で10分間滅菌する。この培地
にブレビバクテリウム・プロトフオルミエ
IFO12128を1白金耳接種し、30℃で18時間振と
う培養する。上記培養液3から遠心分離により
集めた菌体を1−(4−メトキシフエニル)−2−
プロパノン4.9g、塩化アンモニウム40.1g、1M
−トリス塩酸緩衝液300ml及び1%臭化セチルト
リメチルアンモニウム水溶液30mlを予め溶かした
基質水溶液約2.5(PH8.0)に懸濁し、水を加え
て3とする。この懸濁液を30℃で2日間反応さ
せることにより、(R)−1−(4−メトキシフエ
ニル)−2−アミノプロパンが生成する。遠心分
離で菌体を除き得られた上清に1%水酸化ナトリ
ウム溶液を加えPHを11.0とした後、酢酸エチルで
抽出し減圧乾固する。少量の酢酸エチルを加え溶
解し不溶物をろ去した後、10%塩酸を含むイソプ
ロピルアルコールを加え、析出した結晶をろ取す
ることにより、(R)−1−(4−メトキシフエニ
ル)−2−アミノプロパン塩酸塩0.4gを得る。Example 1 Glucose 0.5%, peptone 1%, meat extract 1
%, enzyme extract 1.25%, and sodium chloride 0.5% (PH 7.0) was placed in a 500 ml shake flask and sterilized at 120°C for 10 minutes. Brevibacterium protoformiae was added to this medium.
Inoculate one platinum loop of IFO12128 and culture with shaking at 30°C for 18 hours. 1-(4-methoxyphenyl)-2-
Propanone 4.9g, ammonium chloride 40.1g, 1M
- Suspend 300 ml of Tris-HCl buffer and 30 ml of 1% cetyltrimethylammonium bromide aqueous solution in a pre-dissolved substrate aqueous solution of approximately 2.5 (PH 8.0), and add water to make 3. By reacting this suspension at 30° C. for 2 days, (R)-1-(4-methoxyphenyl)-2-aminopropane is produced. Cells were removed by centrifugation, and 1% sodium hydroxide solution was added to the resulting supernatant to adjust the pH to 11.0, followed by extraction with ethyl acetate and drying under reduced pressure. After adding a small amount of ethyl acetate to dissolve and filtering off insoluble materials, isopropyl alcohol containing 10% hydrochloric acid was added and the precipitated crystals were collected by filtration to obtain (R)-1-(4-methoxyphenyl)- 0.4 g of 2-aminopropane hydrochloride is obtained.
〔α〕20 D:−22.8゜(C=0.5、H2O)
光学純度:100%
実施例 2
ブレビバクテリウム・リネンスIFO12141を用
い実施例1と同様に培養を行う。培養液1から
遠心分離により集めた菌体を1−(4−メトキシ
フエニル)−2−プロパノン1.6g、塩化アンモニ
ウム13.4g、1M−トリス塩酸緩衝液100ml及び1
%臭化セチルトリメチルアンモニウム水溶液10ml
を予め溶かした基質溶液約800ml(PH8.0)に懸濁
し、水を加えて1とする。[α] 20 D : -22.8° (C=0.5, H 2 O) Optical purity: 100% Example 2 Brevibacterium linens IFO12141 was cultured in the same manner as in Example 1. The bacterial cells collected by centrifugation from culture solution 1 were mixed with 1.6 g of 1-(4-methoxyphenyl)-2-propanone, 13.4 g of ammonium chloride, 100 ml of 1M Tris-HCl buffer and 1
% cetyltrimethylammonium bromide aqueous solution 10ml
Suspend in approximately 800 ml of pre-dissolved substrate solution (PH8.0) and add water to make 1.
この懸濁液を30℃で2日間反応させると(S)
−1−(4−メトキシフエニル)−2−アミノプロ
パン0.8gが生成する。実施例1と同様に精製を
行うことにより(S)−1−(4−メトキシフエニ
ル)−2−アミノプロパン0.7gを得る。 When this suspension is reacted at 30℃ for 2 days (S)
0.8 g of -1-(4-methoxyphenyl)-2-aminopropane is produced. Purification is carried out in the same manner as in Example 1 to obtain 0.7 g of (S)-1-(4-methoxyphenyl)-2-aminopropane.
〔α〕20 D:+22.8゜(C=2、H2O)
光学純度:100%
実施例 3
ブレビバクテリウム・リネンスIFO12141を用
い実施例1と同様に培養を行う。培養液10mlから
遠心分離により集めた菌体を1−(4−メトキシ
フエニル)−2−プロパノン16.4mg、塩化アンモ
ニウム134mg、ニコチンアミドアデニンジヌクレ
オチド(還元型)70mg、1M−トリス塩酸緩衝液
1ml及び1%臭化セチルトリメチルアンモニウム
水溶液0.1mlを予め溶かした基質溶液10ml(PH
8.0)に懸濁する。[α] 20 D : +22.8° (C=2, H 2 O) Optical purity: 100% Example 3 Brevibacterium linens IFO12141 is cultured in the same manner as in Example 1. Bacterial cells collected by centrifugation from 10 ml of culture solution were mixed with 16.4 mg of 1-(4-methoxyphenyl)-2-propanone, 134 mg of ammonium chloride, 70 mg of nicotinamide adenine dinucleotide (reduced form), and 1 ml of 1M Tris-HCl buffer. and 10 ml of substrate solution (PH
8.0).
この懸濁液を30℃で2日間反応させることによ
り(S)−1−(4−メトキシフエニル)−2−ア
ミノプロパン16mgを得る。(転換率100%) By reacting this suspension at 30°C for 2 days, 16 mg of (S)-1-(4-methoxyphenyl)-2-aminopropane was obtained. (conversion rate 100%)
Claims (1)
ンから1−(4−メトキシフエニル)−2−アミノ
プロパンを生成させる能力を有するブレビバクテ
リウム属微生物の培養液、該培養液から採取した
菌体、または菌体の処理物を1−(4−メトキシ
フエニル)−2−プロパノンに作用させ、生成し
た1−(4−メトキシフエニル)−2−アミノプロ
パンを採取することを特徴とする1−(4−メト
キシフエニル)−2−アミノプロパンの製法。1 A culture solution of a Brevibacterium microorganism having the ability to produce 1-(4-methoxyphenyl)-2-aminopropane from 1-(4-methoxyphenyl)-2-propanone, collected from the culture solution It is characterized by allowing bacterial cells or a processed product of bacterial cells to act on 1-(4-methoxyphenyl)-2-propanone and collecting the generated 1-(4-methoxyphenyl)-2-aminopropane. A method for producing 1-(4-methoxyphenyl)-2-aminopropane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10838187A JPS63273486A (en) | 1987-04-30 | 1987-04-30 | Production of 1-(4-methoxyphenyl)-2-aminopropane |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10838187A JPS63273486A (en) | 1987-04-30 | 1987-04-30 | Production of 1-(4-methoxyphenyl)-2-aminopropane |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63273486A JPS63273486A (en) | 1988-11-10 |
JPH0411194B2 true JPH0411194B2 (en) | 1992-02-27 |
Family
ID=14483328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10838187A Granted JPS63273486A (en) | 1987-04-30 | 1987-04-30 | Production of 1-(4-methoxyphenyl)-2-aminopropane |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63273486A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015682A1 (en) * | 1995-10-23 | 1997-05-01 | Kaneka Corporation | Process for producing optically active amino compounds |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300437A (en) * | 1989-06-22 | 1994-04-05 | Celgene Corporation | Enantiomeric enrichment and stereoselective synthesis of chiral amines |
US5169780A (en) * | 1989-06-22 | 1992-12-08 | Celgene Corporation | Enantiomeric enrichment and stereoselective synthesis of chiral amines |
US4950606A (en) * | 1989-06-22 | 1990-08-21 | Celgene Corporation | Enantiomeric enrichment and stereoselective synthesis of chiral amines |
DE69841075D1 (en) | 1997-04-23 | 2009-10-01 | Kaneka Corp | Deoxynucleic acid which encodes a polypeptide with stereoselective transaminase activity, as well as the deoxynucleic acid-containing transformants |
US6432688B1 (en) | 1999-01-18 | 2002-08-13 | Daicel Chemical Industries, Ltd. | Amino alcohol dehydrogenase converts keto alcohol to amino alcohol and amino alcohol to keto alcohol |
CN102341494B (en) | 2009-01-08 | 2014-10-15 | 科德克希思公司 | Transaminase polypeptides |
JP5707344B2 (en) | 2009-02-26 | 2015-04-30 | コデクシス, インコーポレイテッド | Transaminase biocatalyst |
SG177329A1 (en) | 2009-06-22 | 2012-02-28 | Codexis Inc | Transaminase reactions |
US8852900B2 (en) | 2010-06-17 | 2014-10-07 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (S)-3-(1-aminoethyl)-phenol |
US8932836B2 (en) | 2010-08-16 | 2015-01-13 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (1R,2R)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine |
-
1987
- 1987-04-30 JP JP10838187A patent/JPS63273486A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015682A1 (en) * | 1995-10-23 | 1997-05-01 | Kaneka Corporation | Process for producing optically active amino compounds |
Also Published As
Publication number | Publication date |
---|---|
JPS63273486A (en) | 1988-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0411194B2 (en) | ||
US4111749A (en) | Method of converting racemic hydantoins into optically active aminoacids | |
JPS5922516B2 (en) | Method for producing L-phenylalanine | |
JP2696127B2 (en) | Method for producing optically active 2-hydroxycarboxylic acid | |
JP3155448B2 (en) | Method for producing L-amino acid or salt thereof | |
JPH01320991A (en) | Production of d-homophenylalanines | |
JPH06141888A (en) | Production of d-mandelic acid | |
EP0110422A2 (en) | Process for producing L-aspartic acid | |
JP3055711B2 (en) | Method for producing optically active (S) -3-phenyl-1,3-propanediol | |
JP2716477B2 (en) | Method for producing S-carboxymethyl-L-cysteine | |
JPH04341195A (en) | Production of optically active mandelic acid | |
JP3117790B2 (en) | Method for producing L-α-aminoadipic acid | |
JP3433300B2 (en) | Highly producing yeast cell wall lytic enzyme and method for lysing yeast cell wall using the same | |
JPS6125359B2 (en) | ||
JP2674078B2 (en) | Process for producing D-α-amino acid | |
JPH0716428B2 (en) | Method for producing L-amino acid | |
JPS6154397B2 (en) | ||
JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
JPH0591895A (en) | Production of d-serine | |
JPH04234993A (en) | Production of optically active alpha-methylbenzylamine | |
JP2899071B2 (en) | Method for producing L-α-alanine | |
US20010036660A1 (en) | Method of producing optically active N-methylamino acids | |
JPH06102027B2 (en) | Method for producing L-2-amino-4-phenylbutyric acid | |
JPS6225353B2 (en) | ||
JPH0438398B2 (en) |